Gland Pharma Limited (GLAND.NS)
INR 1403.5
(0.25%)
INR 1403.5
(0.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.6 Billion INR | -14.39% |
| 2022 | 19.39 Billion INR | -14.76% |
| 2021 | 22.74 Billion INR | 17.76% |
| 2020 | 19.31 Billion INR | 31.43% |
| 2019 | 14.69 Billion INR | 29.37% |
| 2018 | 11.36 Billion INR | 23.58% |
| 2017 | 9.19 Billion INR | 2.52% |
| 2016 | 8.96 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.43 Billion INR | -21.22% |
| 2024 Q2 | 3.61 Billion INR | 5.22% |
| 2023 FY | 16.6 Billion INR | -14.39% |
| 2023 Q2 | 8.51 Billion INR | 12.71% |
| 2023 Q3 | 9.45 Billion INR | 11.04% |
| 2023 Q1 | 7.55 Billion INR | 79.88% |
| 2023 Q4 | 4.35 Billion INR | -53.91% |
| 2022 Q1 | 4.82 Billion INR | -10.78% |
| 2022 FY | 19.39 Billion INR | -14.76% |
| 2022 Q4 | 4.2 Billion INR | -17.81% |
| 2022 Q3 | 5.11 Billion INR | -2.61% |
| 2022 Q2 | 5.24 Billion INR | 8.72% |
| 2021 FY | 22.74 Billion INR | 17.76% |
| 2021 Q4 | 5.41 Billion INR | -3.35% |
| 2021 Q3 | 5.59 Billion INR | 0.62% |
| 2021 Q2 | 5.56 Billion INR | -9.87% |
| 2021 Q1 | 6.17 Billion INR | 35.11% |
| 2020 Q1 | 5.43 Billion INR | 70.7% |
| 2020 Q2 | 4.57 Billion INR | -15.69% |
| 2020 Q3 | 4.52 Billion INR | -1.19% |
| 2020 FY | 19.31 Billion INR | 31.43% |
| 2020 Q4 | 4.56 Billion INR | 0.97% |
| 2019 FY | 14.69 Billion INR | 29.37% |
| 2019 Q4 | 3.18 Billion INR | -13.64% |
| 2019 Q3 | 3.68 Billion INR | 0.0% |
| 2019 Q1 | 3.88 Billion INR | 0.0% |
| 2018 FY | 11.36 Billion INR | 23.58% |
| 2017 FY | 9.19 Billion INR | 2.52% |
| 2016 FY | 8.96 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott India Limited | 26.16 Billion INR | 36.551% |
| Cipla Limited | 161.81 Billion INR | 89.74% |
| GlaxoSmithKline Pharmaceuticals Limited | 12.82 Billion INR | -29.499% |
| Kopran Limited | 2.12 Billion INR | -680.702% |
| Marksans Pharma Limited | 7.71 Billion INR | -115.224% |
| NGL Fine-Chem Limited | 1.23 Billion INR | -1247.076% |
| Pfizer Limited | 9.9 Billion INR | -67.607% |
| Sanofi India Limited | 16.32 Billion INR | -1.696% |
| SMS Pharmaceuticals Limited | 2.1 Billion INR | -687.059% |
| TTK Healthcare Limited | 2.68 Billion INR | -517.988% |